EU Drug Regulator Starts Rolling Review of Sinovac
Posted on 2021-05-04 19:11:05
The European Union's drug regulator says it has started a rolling review of China's Sinovac coronavirus vaccine to assess its effectiveness and safety.
It is the first step toward possible approval for use in the 27-nation bloc.
During a rolling review, drugmakers submit their study data in increments instead of waiting for research to be completed in order to speed up the process.
The European Medicines Agency says that its decision to start the review is based on preliminary results from laboratory studies and clinical studies.
The EMA adds that no application has yet been submitted for marketing authorization for the vaccine.
Customer Service Hotline: 02-8522-7177 | Email: icrtclub@icrt.com.tw Customer Service Hours: Monday-Friday 10AM-6PM nternational Community Radio Taipei 19-5F, No. 5, Sec. 3, New Taipei Blvd., Xinzhuang Dist., New Taipei City 24250